Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results
Go back to Larimar Therapeutics Reports Third Quarter 2021 Operating and Financial Results| (NASDAQ: LRMR) | Delayed: 4.20 -0.12 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.32 | 52 Week High | $ | |||
| Open | $4.31 | 52 Week Low | $ | |||
| Day High | $4.35 | P/E | N/A | |||
| Day Low | $4.13 | EPS | $ | |||
| Volume | 384,106 | |||||

